- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02476357
A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection
A Randomized Control Trial for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the present study was to assess the value of USS in RLND in groin and axilla in a homogenous group of patients.
In a tertiary academic centre, patients undergoing groin or axillary RLND or CLND after positive SLNB for melanoma, skin cancer, sarcoma or breast cancer were enrolled in a randomized controlled trial for surgical dissection technique. The study was reviewed and accepted by the local ethical committee. Patients were older than 18 years and gave an informed consent. All patients with a past medical history of contralateral lymph node dissection or other cause of lymphedema (previous trauma, deep venous thrombosis, radiotherapy, etc.) were excluded. Patients undergoing both iliac and inguinal lymph node dissections were excluded as well. No patients had distant or in transit metastasis. Patients were randomly assigned using sealed numbered envelopes to one of two arms of the study in a 1: 1 ratio. In the first group the dissection was conducted with USS (Harmonic Focus ®, Ethicon Endo-Surgery (Europe) GmbH) exclusively. In the control group the lymphadenectomy was performed using ligation and monopolar electrocautery. All patients were operated by a dedicated team headed by a single surgeon.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Department of Visceral Surgery, University Hospital Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All adult patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND), after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were included.
Exclusion Criteria:
- Patient with a past medical history of contralateral lymph node dissection or other cause for lymphedema (trauma, deep venous thrombosis, radiotherapy, etc.) were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Harmonic
Harmonic Scalpel (HS; Ethicon Endo-Surgery, Cincinnati, OH)
|
|
Active Comparator: Control
Monopolar scalpel and ligature
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative Draining Time
Time Frame: Lymph quantity measured every day. Drained removed when < 50 ml. per day for 2 consecutive days
|
Duration (days) between surgery and removal of postoperative suction drain
|
Lymph quantity measured every day. Drained removed when < 50 ml. per day for 2 consecutive days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily Amount of Drained Lymph
Time Frame: Lymph quantity measured every day, up to 50 days.
|
Patients had to record on a list the amount in ml. of lymph in the suction drain bottles
|
Lymph quantity measured every day, up to 50 days.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Maurice Matter, Prof, Lausanne University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LYMPH-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphoedema
-
Tactile MedicalCompletedLower Extremity Lymphoedema | Leg LymphoedemaUnited Kingdom
-
Cwm Taf University Health Board (NHS)University of South WalesCompletedLymphoedema of LegUnited Kingdom
-
University of South WalesCwm Taf University Health Board (NHS)CompletedLymphoedemaUnited Kingdom
-
Universitaire Ziekenhuizen KU LeuvenRecruitingLymphedema | Lymphedema Arm | Lymphoedema of LegBelgium
-
Fundación de Investigación Biomédica - Hospital...Completed
-
University Hospital, MontpellierCompleted
-
PureTechNovotech (Australia) Pty LimitedTerminatedLymphoedema | Breast Cancer Related LymphoedemaUnited States, Australia
-
Hospital of South West JutlandCompleted
-
Norfolk and Norwich University Hospitals NHS Foundation...CompletedBreast Cancer Related LymphoedemaUnited Kingdom
Clinical Trials on Harmonic scalpel
-
Barretos Cancer HospitalCompletedComplication, PostoperativeBrazil
-
Dartmouth-Hitchcock Medical CenterEthicon Endo-SurgeryTerminated
-
Brazilian Society of Head and Neck SurgeryJohnson & JohnsonUnknown
-
University of CalgaryCompleted
-
Sentara Cardiovascular Research InstituteEthicon Endo-SurgeryRecruiting
-
University of Roma La SapienzaCompleted
-
Samsung Medical CenterCompleted
-
Mr Andrew KentCompleted
-
St Andrew's Centre for Plastic SurgeryWithdrawnBreast ReconstructionUnited Kingdom
-
Hippocration General HospitalCompleted